CD274 and melanoma: While several studies have linked EV PD-L1 with resistance to ICI in melanoma [289, 294, 299], this association was not clearly found with soluble PD-L1 which has been even linked to a greater likelihood of developing a partial response on CTLA4 blockade after five months of treatment [300].